Proteomics of prostate cancer patient derived xenografts

ABSTRACT: A set of 17 prostate cancer patient-derived xenografts (PDX, Lin et al 2014, Cancer research) was analyzed by mass spectrometry-based proteomics to characterize the effects of castration in vivo, and the proteome differences between NEPC and prostate adenocarcinomas.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Prostate Cancer Cell

DISEASE(S): Prostate Adenocarcinoma

SUBMITTER: Diego Iglesias-Gato  

LAB HEAD: Diego Iglesias-Gato

PROVIDER: PXD009636 | Pride | 2019-09-11

REPOSITORIES: Pride